MYC and nasopharyngeal neoplasm: The study of Yu and colleagues showed that patients with c-Myc positive nasopharyngeal tumors had lower recurrence and death rates (38% (11/29) and 34% (10/29), respectively) than those with c-Myc negative tumors (73% (16/22) and 64% (14/22), respectively) [127].